Precigen Investor
Precigen is a life sciences company researching and developing bio-therapeutic control systems to minimize toxicity.
Technology:
CAR-T therapy, Cell_Therapies
Industry:
Public
Headquarters:
Germantown, Maryland, United States
Founded Date:
1998-01-01
Employees Number:
251-500
Funding Status:
IPO
Number Of Exits:
1
Investors Number:
3
Total Funding:
600803901
Estimated Revenue:
$10M to $50M
Last Funding Date:
2023-01-24
Last Funding Type:
Post-IPO Equity
Register and Claim Ownership